Deep time: the long and the short of adjuvant endocrine therapy for breast cancer
- PMID: 22271478
- DOI: 10.1200/JCO.2011.40.1455
Deep time: the long and the short of adjuvant endocrine therapy for breast cancer
Comment on
-
Disease-related outcomes with long-term follow-up: an updated analysis of the intergroup exemestane study.J Clin Oncol. 2012 Mar 1;30(7):709-17. doi: 10.1200/JCO.2010.33.7899. Epub 2011 Oct 31. J Clin Oncol. 2012. PMID: 22042946 Clinical Trial.
-
Longer-term outcomes of letrozole versus placebo after 5 years of tamoxifen in the NCIC CTG MA.17 trial: analyses adjusting for treatment crossover.J Clin Oncol. 2012 Mar 1;30(7):718-21. doi: 10.1200/JCO.2010.34.4010. Epub 2011 Oct 31. J Clin Oncol. 2012. PMID: 22042967 Free PMC article. Clinical Trial.
-
Tamoxifen and anastrozole as a sequencing strategy: a randomized controlled trial in postmenopausal patients with endocrine-responsive early breast cancer from the Austrian Breast and Colorectal Cancer Study Group.J Clin Oncol. 2012 Mar 1;30(7):722-8. doi: 10.1200/JCO.2011.36.8993. Epub 2012 Jan 23. J Clin Oncol. 2012. PMID: 22271481 Clinical Trial.
Similar articles
-
Overview of adjuvant trials of aromatase inhibitors in early breast cancer.Steroids. 2011 Jul;76(8):765-7. doi: 10.1016/j.steroids.2011.02.021. Epub 2011 Mar 4. Steroids. 2011. PMID: 21382394
-
Current developments in hormonal therapy of breast cancer.Clin Breast Cancer. 2004 Sep;5 Suppl 1:S4-5. doi: 10.3816/cbc.2004.s.007. Clin Breast Cancer. 2004. PMID: 15347432 Review. No abstract available.
-
[Antiestrogen treatment in postmenopausal patients with metastatic breast cancer].Ugeskr Laeger. 2007 Sep 10;169(37):3096-100. Ugeskr Laeger. 2007. PMID: 17877958 Review. Danish.
-
Recent advances in aromatase inhibitor therapy for breast cancer.Semin Oncol. 2002 Jun;29(3 Suppl 11):120-8. doi: 10.1053/sonc.2002.34064. Semin Oncol. 2002. PMID: 12138406 Review.
-
Adjuvant aromatase inhibitor therapy for early breast cancer: A review of the most recent data.J Surg Oncol. 2006 Jun 1;93(7):585-92. doi: 10.1002/jso.20564. J Surg Oncol. 2006. PMID: 16705732 Review.
Cited by
-
The GALNT9, BNC1 and CCDC8 genes are frequently epigenetically dysregulated in breast tumours that metastasise to the brain.Clin Epigenetics. 2015 May 27;7(1):57. doi: 10.1186/s13148-015-0089-x. eCollection 2015. Clin Epigenetics. 2015. PMID: 26052355 Free PMC article.
-
Apolipoprotein D expression does not predict breast cancer recurrence among tamoxifen-treated patients.PLoS One. 2017 Mar 16;12(3):e0171453. doi: 10.1371/journal.pone.0171453. eCollection 2017. PLoS One. 2017. PMID: 28301514 Free PMC article.
-
A gene signature for late distant metastasis in breast cancer identifies a potential mechanism of late recurrences.Mol Oncol. 2013 Oct;7(5):987-99. doi: 10.1016/j.molonc.2013.07.006. Epub 2013 Jul 17. Mol Oncol. 2013. PMID: 23910573 Free PMC article.
-
Late recurrence of breast cancer is associated with pro-cancerous immune microenvironment in the primary tumor.Sci Rep. 2019 Nov 15;9(1):16942. doi: 10.1038/s41598-019-53482-x. Sci Rep. 2019. PMID: 31729458 Free PMC article.
-
Prediction of late disease recurrence and extended adjuvant letrozole benefit by the HOXB13/IL17BR biomarker.J Natl Cancer Inst. 2013 Jul 17;105(14):1036-42. doi: 10.1093/jnci/djt146. Epub 2013 Jun 28. J Natl Cancer Inst. 2013. PMID: 23812955 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical